Attain Commercial Success for your Chronic Inflammatory Skin Diseases Treatment Pipeline
Therapeutic innovation in the dermatology space is growing at an exponential rate, propelling an increase in the awareness and knowledge of inflammatory skin conditions’ pathophysiology.
In turn, a plethora of treatment options for chronic, moderate to severe dermatological diseases, and conditions of high unmet need, which concerns the lives of millions of individuals across the globe. As opportunities in this evolving landscape multiply, organisations and experts are motivated to pool their expertise to accelerate the delivery of innovative therapies to market.
The 3rd Dermatology Drug Development Europe Summit returned as the only end-to-end industry meeting committed to generating new dermatological therapeutics to market through collaboration. This summit delivered an unrivalled prospect to industry experts in the dermatology space. Exploring methods to tackle key challenges and reviewing opportunities in the development and delivery of pioneering dermatology medicines to market.